-
New Nonprofit Launches to Advance Quality Standards for Compounded Peptides
A newly formed nonprofit organization is working to establish quality and safety standards for peptide compounding, aiming to boost consistency and confidence across the industry.
-
Exploring Ways to Reduce Long-Term Risks in Kidney Transplant Care with Belatacept
A clinical trial is investigating whether Nulojix® (belatacept) can help kidney transplant patients avoid the long-term side effects of traditional anti-rejection drugs while still protecting the new organ.
-
New Phase 2/3 Trial Launches to Compare Next-Generation Peptide BMN 333 With Vosoritide in Children With Achondroplasia
A new multinational study is underway to evaluate BMN 333, an investigational peptide therapy, against the approved treatment vosoritide in treatment-naïve children with achondroplasia. The trial marks continued progress in expanding options for this genetic growth condition.
-
New Trial Explores Retreatment with 177Lu-DOTATATE PRRT for Neuroendocrine Tumors
A phase II trial, NET RETREAT, is investigating whether repeating peptide receptor radionuclide therapy with 177Lu-DOTATATE offers better tumor control than standard drug therapies in patients with advanced neuroendocrine tumors who previously responded to this treatment.
-
New Clinical Trial Explores Advanced Cancer Treatment Combinations with Datopotamab Deruxtecan
A new global study, TROPION-PanTumor03, is investigating the potential of Datopotamab Deruxtecan alone and combined with other anti-cancer therapies for patients with advanced solid tumours.
-
New Clinical Trial Launches to Study Pumitamig for Advanced Kidney Cancer
A new clinical trial, ROSETTA RCC-208, is now underway to evaluate the safety, tolerability, and efficacy of the investigational agent Pumitamig, alone or combined with other therapies, in patients with advanced renal cell carcinoma.
-
New Clinical Trial Explores Tirzepatide as Potential Treatment for Methamphetamine Use Disorder
A phase 2 randomized controlled trial is now investigating whether tirzepatide, a peptide already known for its metabolic benefits, could help treat methamphetamine use disorder. The study will assess safety, tolerability, and early signs of effectiveness.
-
New Phase III Trial Explores Targeted Antibody Therapies for HER2-Positive Endometrial Cancer
A new phase III clinical trial is investigating whether adding Herceptin Hylecta or Phesgo to standard chemotherapy can improve outcomes for patients with HER2-positive endometrial serous carcinoma or carcinosarcoma.
-
New Clinical Trial Explores Livmoniplimab-Budigalimab Combination for Liver Cancer
A large global study is testing an investigational peptide-based immunotherapy combination, livmoniplimab and budigalimab, against current standard treatments for advanced hepatocellular carcinoma.
-
Clinical Trial Explores Enhanced Antibody Therapy for High-Risk Childhood Neuroblastoma
A Phase II pilot study is testing whether pairing a novel anti-GD2 monoclonal antibody, hu14.18K322A, with standard chemotherapy can improve outcomes for children newly diagnosed with high-risk neuroblastoma.